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Description of MisPred tools 
 
1. Constituents of MisPred tools 
 
1.1. Lists of extracellular, cytoplasmic and nuclear Pfam-A domains 
Recent studies have revealed that there is a strong correlation between the domain-
composition of proteins and their subcellular location: some domains are restricted to proteins 
targeted to the extracellular space, others occur only in proteins present in the cytoplasmic 
space, while others are restricted to proteins of the nucleus. Transmembrane multidomain 
proteins are special in the sense that extracellular and cytoplasmic domains can legitimately 
co-occur in a single protein (Tordai et al., 2005). Accordingly, the presence of extracellular, 
cytoplasmic or nuclear domains in a protein may be used to predict its subcellular 
localization, independent of the detection of sorting signals.  
Since domains are most likely to co-occur in multidomain proteins if they belong to 
the same localization-category, analysis of domain co-occurrence networks is useful for the 
systematic assignment of domains to different subcellular compartments (Tordai et al., 2005). 
Our domain co-occurrance analyses of Metazoan UniProtKB entries have identified 
166 extracellular, 115 cytoplasmic and 126 nuclear Pfam-A domain families as being 
restricted to the respective subcellular compartment, the majority of which are also identified 
as such in the SMART database http://smart.embl-heidelberg.de/ (see 
http://www.mispred.com/table1to3).  
In our MisPred analyses only these extracellular or cytoplasmic or nuclear domain 
families were used to predict subcellular localization. Pfam-A domains that are known not to 
be restricted to a particular cellular compartment, such as immunoglobulin domains, 
fibronectin type III domains, von Willebrand factor type A domains (i.e. domains that are 
'multilocale'), are not reliable predictors of subcellular localization and thus they were not 
utilized in these analyses. 
 
 
1.2. Programs used for the identification of Pfam-A domains 
The programs of the HMMER 3.0 software package were used to detect Pfam-A 
domains in proteins (Finn et al. 2011; Punta et al. 2012). Pfam-A domains were detected by 
searching the HMM databases with the hmmscan program using 1e-6 as per-domain E-value 
threshold. The results were filtered for overlapping domain matches and only the match with 
the lowest E-value was accepted. 
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The HMMER software package was obtained from http://hmmer.janelia.org/. HMM 
databases of Pfam-A domains were created by retrieving the HMMs of the domains from 
Pfam HMM libraries downloaded from ftp://ftp.sanger.ac.uk/pub/databases/Pfam/. The local 
Pfam HMM libraries will be updated twice a year.  
 
1.3. Programs used for the identification of secretory signal peptides 
 Proteins were analyzed with the PrediSi program (Hiller et al. 2004), the SignalP 3.0 
program (Bendtsen et al. 2004) to identify the presence of eukaryotic signal peptide 
sequences. 
The PrediSi program was downloaded from http://www.predisi.de/, the SignalP 
program was downloaded from http://www.cbs.dtu.dk/cgi-bin/sw_request?signalp+3.0. 
 
1.4. Programs used for the identification of transmembrane helices 
Proteins were analyzed with the TMHMM 2.0 program (Krogh et al. 2001) and the 
Phobius program (Käll et al. 2007) to detect the presence of transmembrane helices.  
The TMHMM program was obtained from http://www.cbs.dtu.dk/services/TMHMM/. 
The Phobius program was obtained from http://software.sbc.su.se/cgi-
bin/request.cgi?project=phobius. 
 
1.5. Program used for the identification of GPI-anchors 
Protein sequences were analyzed with the DGPI program (Kronegg and Buloz, 1999) 
to identify GPI-anchors.  
The DGPI program was obtained from http://dgpi.pathbot.com/. 
 
1.6. Program used for the chromosomal localization of exons encoding a 
protein 
The protein sequences were matched to the genome of the given species using the 
BLAT program (Kent, 2002).  
The BLAT program was obtained from http://genome-test.cse.ucsc.edu/~kent/exe/. 
 
 
2. MisPred tool logic 
 
Tool 1.  
Conflict between the presence of extracellular protein domain(s) in a protein and 
the absence of appropriate sequence signals that could direct the extracellular domain(s) 
into the extracellular space.   
 Proteins found to contain extracellular Pfam-A domains were analyzed by the PrediSi 
program (using 0.3 as threshold) and the SignalP 3.0 program to identify the presence of 
program to detect the presence of transmembrane helices.  
eukaryotic signal peptide sequences and by the TMHMM 2.0 program and the Phobius 
Protein sequences containing extracellular domains but lacking a signal peptide or a 
transmembrane helix were identified as suspicious. 
 
Tool 2.  
Conflict between the presence of extracellular and cytoplasmic domains in a 
protein and the absence of transmembrane helix(ces).  
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 Proteins found to contain both extracellular and cytoplasmic Pfam-A domains were 
analyzed by the TMHMM 2.0 and the Phobius programs to detect transmembrane helices.  
Sequences containing both extra- and cytoplasmic domains (i.e. putative 
transmembrane proteins) but lacking a transmembrane helix were identified as suspicious. 
 
Tool 3.  
Co-occurrence of extracellular and nuclear domains in a protein.   
 Protein found to contain both extracellular and nuclear Pfam-A domains were 
identified as suspicious. 
 
Tool 4.  
Domain size deviation.  
The rationale of this tool is that the number of amino acid residues in a Pfam-A 
domain-family usually falls in a relatively narrow range. MisPred tool 4 uses only Pfam-A 
domain families that have a well-defined, conserved sequence length range: their members in 
the high quality Swiss-Prot database do not deviate from the average size by more than 2 
standard deviation (SD) values. Based on these criteria, about 90% of the Pfam-A domain 
families present in Swiss-Prot proteins proved to be suitable for the study of domain integrity. 
The lists of Pfam-A domain families suitable for the study of domain integrity are shown in 
http://www.mispred.com/table4. 
We created local databases of human, vertebrate and metazoa+fungi Swiss-Prot 
domain sequences belonging to the Pfam-A families suitable for the study of domain integrity 
and ran a blastp search with the protein queries against the appropriate Swiss-Prot domain 
sequences.  
MisPred tool 4 selects those partial domain matches which share over 60% identity 
with the query sequence, with an E-value < 1e-5 but they differ in length by at least 40%.  
Protein sequences containing domains with such deviant lengths were identified as suspicious. 
 
Tool 5.  
Interchromosomal chimeric proteins.  
 MisPred tool 5 matches protein sequences to the genome of the given species using the 
BLAT program and lists matches with >95% identity over ≥ 15 amino acid residues in length. 
In the case of overlapping matches (if the overlap was >5 residues) the tool selects the longest 
match. To eliminate problems encountered with genes originating from the mitochondrial 
genome MisPred tool 5 uses an additional BLAT search and discards those entries which gave 
>90% match with the mitochondrial genome over more than 90% of their length.  
 MisPred tool 5 identifies proteins as interchromosomal chimeras if two or more of 
their segments are encoded on different chromosomes.  
 
Tool 6.  
Conflict between the presence of secretory signal peptide and cytoplasmic protein 
domains in a protein and the absence of transmembrane segments.   
 Proteins found to contain cytoplasmic Pfam-A domains were analyzed by the PrediSi 
and the SignalP 3.0 programs to identify the presence of eukaryotic signal peptide sequences 
and by the TMHMM 2.0 and the Phobius programs to detect the presence of transmembrane 
helices.  
 Protein sequences containing cytoplasmic domains and signal peptide sequences (i.e. 
putative transmembrane proteins) but lacking a transmembrane helix were identified as 
suspicious. 
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Tool 7.  
Conflict between the presence of GPI-anchor in a protein and the absence of 
secretory signal peptide.  
 Protein sequences were analyzed with the DGPI program to identify GPI-anchors. 
Proteins predicted to contain a GPI-anchor were analyzed with the PrediSi and the SignalP 3.0 
programs to identify the presence of eukaryotic signal peptide sequences.  
 Proteins that contain a GPI-anchor but lack a secretory signal peptide were identified 
as suspicious. 
 
Tool 8.  
Co-occurrence of GPI-anchor and cytoplasmic protein domains in a protein.    
 Protein sequences were analyzed with the DGPI program to identify GPI-anchors. 
Proteins predicted to contain a GPI-anchor were analyzed with the hmmscan program to 
identify the presence of cytoplasmic Pfam-A domains.  
 Protein sequences containing both GPI-anchor and cytoplasmic domains are identified 
as suspicious. 
 
Tool 9.  
Co-occurrence of GPI-anchor and nuclear protein domains in a protein.  
 Protein sequences were analyzed with the DGPI program to identify GPI-anchors. 
Proteins predicted to contain a GPI-anchor were analyzed with the hmmscan program to 
identify the presence of nuclear Pfam-A domains.  
 Protein sequences containing both GPI-anchor and nuclear domains are identified as 
suspicious. 
 
Tool 10.  
Co-occurrence of GPI-anchor and transmembrane segments in a protein.  
 Protein sequences were analyzed with the DGPI program to identify GPI-anchors. 
Proteins predicted to contain a GPI-anchor were analyzed with the TMHMM 2.0 and Phobius 
programs to identify the presence of transmembrane segments.  
 Protein sequences containing both GPI-anchor and transmembrane segments are 
identified as suspicious. 
 
Tool 11.  
Domain architecture deviation.  
The rationale of this tool is that changes in domain architecture of proteins are 
relatively rare evolutionary events (whereas the error rate in gene prediction is relatively 
high), therefore if we find a protein whose domain architecture differs from those of its 
orthologs then this is more likely to reflect an error in gene prediction than true change in 
domain architecture.  
MisPred tool 11 searches protein sequences for the presence of domains using RPS-
BLAST against the Conserved Domain Database using Pfam-derived position-specific 
scoring matrices (Marchler-Bauer et al., 2013). The tool records domain hits with an e-value 
of <1e-5, eliminates overlapping hits and determines the domain architecture (DA, linear 
sequence of domains) at four different e-value cut-offs of domain hits: <1e-2, <1e-3, <1e-4 
and <1e-5. The tool compares the DA with those of orthologs and in the case of DA 
difference (at all cut-off values) it recalculates their DA using the programs of the HMMER 
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3.0 software package and the Pfam HMM libraries at four different e-value cut-offs: <1e-2, 
<1e-3, <1e-4 and <1e-5. 
MisPred tool 11 identifies protein sequences that differ in domain architecture (at any 
single cut-off value) from those of its orthologs as suspicious. 
 
 
3. Specificity and sensitivity of MisPred tools 
 
 We have performed extensive analyses to optimize specificity and sensitivity of the 
various MisPred tools. False positive rates of the tools were monitored on high quality 
datasets (e.g. Swiss-Prot database) that are practically free of erroneous sequences. False 
negative rates of the tools were monitored on datasets of erroneous sequences generated 
artificially from correct Swiss-Prot sequences. 
 
3.1. False positive rates and specificity 
 To calculate the false positive rate (α) and specificity (1-α) of MisPred tools from the 
equation α = FP/(FP+TN), we have determined the number of false positives (FP) and true 
negatives (TN) from the results obtained by application of MisPred tools to high quality 
Swiss-Prot entries.  
 Considering that Swiss-Prot is a very clean database, in these calculations FP equaled 
the number of Swiss-Prot entries that were identified with the given method as suspicious 
(although they do not violate the given dogma), whereas the entries not identified by MisPred 
as suspicious were assumed to be true negatives (TN), i.e. they do not violate the given 
dogma.  
To monitor false positive rate of MisPred tool 11 we have randomly selected 500 pairs 
of orthologous human, pongo, rat, mouse, chick, frog, zebrafish, worm and fly Swiss-Prot 
sequences from the list of orthologs and retained only pairs that align over their entire length 
and had identical domain architecture as evidenced by Swiss-Prot annotation.  
The false positive rates of the MisPred routines 1-6 and 11 were calculated to be ≤ 
0.015, i.e. their specificity is very high (≥ 0,985). The high specificity of these tools reflects 
the fact that the constituent programs have high specificity and that these MisPred tools are 
based on generally valid ‘dogmas’ about proteins.  
The false positive rates of the MisPred routines 7-10 were calculated to be 0,153, 
0,149, 0,155 and 0,151, respectively, i.e. their specificities are significantly lower than those 
10 reflects the fact that the DGPI constituent of these tools overpredicts GPI-anchors. On the 
identified by MisPred tools 7-10 the false positive rate is relatively high. The specificity data 
of MisPred tools are summarized in Supplementary Table 1. 
of the MisPred tools 1-6 and 11. The relatively high false positive rate of MisPred routines 7-
RESULTS page of the MisPred website users are cautioned that in the case of errors 
 
3.2 False negative rates and sensitivity 
We have monitored the false negative rates of the various MisPred tools on datasets of 
artificially created erroneous sequences that violate the dogma underlying the given tool. The 
false negative rate (β) and sensitivity (1-β) of the MisPred tools were calculated from the 
equation β = FN/(TP + FN). Since all entries in the given dataset violate the given dogma, 
entries detected by MisPred as suspicious are true positives (TP), whereas those not detected 
by MisPred are false negatives (FN). 
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The MisPred routine for tool 1 detected 88,2% of the erroneous entries generated from 
secreted proteins containing an extracellular Pfam-A domain from which the N-terminal 50 
residues (that might contain secretory signal peptide) were removed. 
The MisPred routine for tool 2 detected 84,8% of the erroneous entries generated from 
transmembrane proteins containing both an extracellular and a cytoplasmic Pfam-A domain 
after removing their transmembrane helices. 
The sensitivity of the MisPred routine for tool 3 was found to be 99,9% when we 
applied it to chimeric proteins generated by fusion of human Swiss-Prot proteins containing 
extracellular domains to proteins containing nuclear domains. 
The sensitivity of the MisPred routine for tool 4 was found to 92,5% when we applied 
it to proteins generated by deleting 50% of the residues from the N-terminal, C-terminal and 
internal regions of Pfam-A domains suitable for the detection of domain size deviation.  
The sensitivity of the MisPred routine for tool 5 was found to be 92,9%, when tested 
on artificial chimeras generated by random fusion of genes encoded on different 
chromosomes. 
 The MisPred routine for tool 6 detected 84,6% of the erroneous entries generated from 
transmembrane proteins containing both a signal peptide and a cytoplasmic Pfam-A domain 
after removing their transmembrane helices. 
 The MisPred routine for tool 7 detected 89,1% of the erroneous entries generated from 
GPI-anchored proteins after removing their signal peptide. 
 The sensitivity of MisPred routines for tools 8, 9 and 10 were found to be 95,2%, 
95,4% and 87,2%, respectively when tested on chimeric proteins generated by fusion of 
human Swiss-Prot proteins containing a GPI-anchor with entries containing cytoplasmic or 
nuclear domains or transmembrane helices. 
The sensitivity of MisPred routine for tool 11 was found to be 86,5% when tested on 
erroneous entries generated by deleting (or inserting) randomly selected Pfam-A domains 
from or into various positions of one member of the pair of orthologous sequences. The 
sensitivity data of MisPred tools are summarized in Supplementary Table 1. 
 
  
4. Datasets analyzed 
We have analyzed protein sequences of 19 Metazoan species deposited in the 
UniProtKB/Swiss-Prot, UniProtKB/TrEMBL (UniProt Consortium, 2012), NCBI/RefSeq 
(Pruitt et al. 2012) and EnsEMBL ( Flicek et al. 2012) databases. 
The UniProtKB Swiss-Prot and TrEMBL entries from UniProtKB release 2012_05 
(May 2012) were downloaded from http://www.uniprot.org. 
The protein sequences of the EnsEMBL database were downloaded from the 
EnsEMBL website, release 67 (May 2012), found at ftp://ftp.ensembl.org/pub/release-67. 
The NCBI/RefSeq protein sequences were downloaded from NCBI website found at 
http://www.ncbi.nlm.nih.gov on May 2012. 
 
References 
 
Bendtsen,J.D. et al. (2004) Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 
340, 783-795. 
Finn,R.D. et al. (2011) HMMER web server: interactive sequence similarity searching. 
Nucleic Acids Res., 39(Web Server Issue), W29-W37. 
Flicek,P. et al. (2012) Ensembl 2012. Nucleic Acids Res., 40(Database Issue), D84-90. 
 6
 7
Hiller,K. et al. (2004) PrediSi: prediction of signal peptides and their cleavage positions. 
Nucleic Acids Res., 32(Web Server Issue), W375-9. 
Käll,L. et al. (2007) Advantages of combined transmembrane topology and signal peptide 
prediction--the Phobius web server. Nucleic Acids Res., 35(Web Server Issue), W429-32. 
Kent,W.J. (2002) BLAT–the BLAST-like alignment tool. Genome Res., 12, 656–664. 
Krogh,A. et al. (2001) Predicting transmembrane protein topology with a hidden Markov 
model: Application to complete genomes. J. Mol. Biol., 305, 567-580. 
Kronegg,J. and Buloz,D. (1999) Detection/prediction of GPI cleavage site (GPI-anchor) in a 
protein (DGPI). http://dgpi.pathbot.com/ 
Marchler-Bauer, A. et al. (2013) CDD: conserved domains and protein three-dimensional 
structure. Nucleic Acids Res. 41(D1), D348-352. 
Pruitt,K.D. et al. (2012) NCBI Reference Sequences (RefSeq): current status, new features 
and genome annotation policy. Nucleic Acids Res., 40(Database Issue), D130-5. 
Punta,M. et al. (2012) The Pfam protein families database. Nucleic Acids Res., 40(Database 
Issue), D 290-301. 
Tordai,H. et al. (2005) Modules, multidomain proteins and organismic complexity. FEBS J., 
272, 5064-78. 
UniProt Consortium (2012) Reorganizing the protein space at the Universal Protein Resource 
(UniProt). Nucleic Acids Res., 40(Database Issue), D71-5. 
 
 
Supplementary Table 1.  
Specificity and sensitivity data of MisPred tools 
 
MisPred tool Specificity Sensitivity 
Tool 1 ≥ 0,985 0,882 
Tool 2 ≥ 0,985 0,848 
Tool 3 ≥ 0,985 0,999 
Tool 4 ≥ 0,985 0,925 
Tool 5 ≥ 0,985 0,929 
Tool 6 ≥ 0,985 0,846 
Tool 7 0,847 0,891 
Tool 8 0,851 0,952 
Tool 9 0,845 0,954 
Tool 10 0,849 0,872 
Tool 11 ≥ 0,985 0,865 
 
 
